A First-in-Human (FIH), Open-Label, Phase 1 Study of ADG206, a CD137 Agonist Antibody, in Subjects with Advanced/Metastatic Solid Tumors

Project: Research

Project Details

StatusActive
Effective start/end date5/12/224/12/27